The FDA has shared draft guidance on the design and development of AI-enabled medical devices and marketing submissions for those devices.
The US Food and Drug Administration has issued guidance urging sponsors and trial sites to consider the necessity of the ...
The U.S. FDA has released a new draft guidance for drugmakers to aid them in developing new treatments for obesity. The new ...
The FDA does not favor commonly used descriptors such as ‘plant-based burger' on labels and suggests brands instead say ...
On December 5, 2024, the U.S. Food and Drug Administration (FDA or Agency) issued a draft guidance entitled Expedited Program for ...
Comment period is open for the public to review the new draft guidelines for labeling plant-based alternative foods.
The document follows the agency’s first digital health advisory meeting and a final guidance on postmarket updates to AI ...
The Food and Drug Administration issued draft guidance Jan. 6 on marketing submissions and lifecycle management for ...